Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03821233
Title A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Zymeworks Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Chicago Medicine Chicago Illinois 60637 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Flinders Medical Centre Adelaide 5042 Australia Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Montreal Quebec H3T1E2 Canada Details
Seoul National University Bundang Hospital Seongnam-si 13620 Korea, Republic of Details
Korea University Anam Hospital Seoul 02841 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field